We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Hewlett Packard
HPE
$63.2B
| $31.6M | 0.44% |
2,113,076
-67,000
| -3% | -$1.02M |
|
52
Jabil
JBL
$32.8B
| $30.3M | 0.42% |
959,592
+98,687
| +11% | +$2.83M |
|
53
Emcor
EME
$33.1B
| $30.1M | 0.42% |
341,330
-5,900
| -2% | -$478K |
|
54
Cencora
COR
$60.3B
| $29.6M | 0.41% |
347,540
+12,879
| +4% | +$1.02M |
|
55
Best Buy
BBY
$18B
| $29.2M | 0.4% |
418,800
+16,900
| +4% | +$1.18M |
|
56
LPL Financial
LPLA
$26.3B
| $28.8M | 0.4% |
353,109
-17,820
| -5% | -$1.41M |
|
57
Lennox International
LII
$18.8B
| $28.3M | 0.39% |
102,876
-41,537
| -29% | -$11.3M |
|
|
58
Ford
F
$57.3B
| $27.8M | 0.38% |
2,716,566
-2,956,230
| -52% | -$29.1M |
|
59
Duke Energy
DUK
$102B
| $27.3M | 0.38% |
309,804
+185,884
| +150% | +$16.4M |
|
60
US Foods
USFD
$21.4B
| $27.2M | 0.38% |
759,972
+379,300
| +100% | +$13.8M |
|
61
VeriSign
VRSN
$25.5B
| $27.1M | 0.38% |
129,600
-17,510
| -12% | -$3.44M |
|
62
Expeditors International
EXPD
$22.9B
| $27.1M | 0.37% |
356,842
+115,540
| +48% | +$8.72M |
|
|
JNPR
63
DELISTED
Juniper Networks
JNPR
| $26.5M | 0.37% |
995,497
-63,980
| -6% | -$1.71M |
|
64
Gilead Sciences
GILD
$161B
| $26.2M | 0.36% |
388,365
+174,475
| +82% | +$11.5M |
|
|
AAN.A
65
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $26.2M | 0.36% |
427,045
-56,854
| -12% | -$3.49M |
|
66
American Tower
AMT
$77.7B
| $25.8M | 0.36% |
126,000
+51,860
| +70% | +$10.4M |
|
67
Ameriprise Financial
AMP
$46.8B
| $25.8M | 0.36% |
177,415
+2,066
| +1% | +$299K |
|
68
Charter Communications
CHTR
$15.2B
| $25.4M | 0.35% |
64,240
+30,008
| +88% | +$11.2M |
|
69
Align Technology
ALGN
$12B
| $25.3M | 0.35% |
92,489
+39,258
| +74% | +$11.9M |
|
70
Molina Healthcare
MOH
$10.3B
| $25.1M | 0.35% |
175,326
+77,361
| +79% | +$10.6M |
|
|
CTRA
71
DELISTED
Coterra Energy
CTRA
| $25.1M | 0.35% |
1,092,290
+794,260
| +267% | +$20.2M |
|
|
CSOD
72
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $24.9M | 0.35% |
430,394
+6,220
| +1% | +$337K |
|
73
Hilton Worldwide
HLT
$74B
| $24.6M | 0.34% |
251,241
-31,310
| -11% | -$2.84M |
|
74
Cirrus Logic
CRUS
$6.74B
| $24.5M | 0.34% |
559,614
-141,249
| -20% | -$6.14M |
|
75
NetApp
NTAP
$32.9B
| $24.2M | 0.34% |
392,582
+141,280
| +56% | +$9.54M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.